A new tool, ASAP, rapidly and reversibly turns autophagy on and off, confirming suspected targets, revealing new ones, and suggesting a link between protein building and breakdown. ASAP also targets nuclear pore complexes and protein condensates, shedding light on autophagy's role in maintaining cellular health.
A new atlas reveals how key human brain cells develop and mature before and after birth, shedding light on cell types linked to schizophrenia and other conditions. The study mapped gene regulation in the developing basal ganglia, a region implicated in Parkinson's disease, Huntington's disease, and addiction.
A new study reveals that slow brain waves, typically associated with deep sleep, are more frequent in Parkinson’s disease patients and correlate with hallucinations and impaired cognition. The findings suggest that slow wave patterns might offer a way to identify people at risk of the condition.
The study reveals that the interior of nuclear pores is fluid-like, with proteins remaining mobile throughout a two-hour observation period. The transport pathway is primarily via the edge of the pore, contrary to earlier hypotheses, and is influenced by the presence of glycosylated barrier proteins.
A Kaiser Permanente study found that most people newly diagnosed with MOGAD fully recovered, with only a few experiencing a relapse, providing a more encouraging picture of the disease than previous research
A new study reveals that the CASS4 gene plays a crucial role in Alzheimer's disease by directing brain-cleaning immune cells, which can be disrupted leading to the buildup of toxic plaques. This discovery offers new hope for the development of treatments or prevention strategies by targeting the gene or microglia in the brain.
The National MS Society is launching a funding opportunity to support innovative screening technologies for early MS detection. The goal is to accelerate progress in identifying individuals at risk of MS, ultimately reducing time to diagnosis and improving long-term outcomes.
A recent study published in Genomic Psychiatry analyzed the Alzheimer's Disease Neuroimaging Initiative and found that people with frequent anxiety scored lower on a standard test of global cognition. The authors suggest that a single serotonin receptor may be responsible for both worry and cognitive decline in Alzheimer's disease.
A research team identified a signaling pathway involving AQP4, TRPA1, BEST1, and D-serine that helps maintain neuronal activity and cerebral blood-volume responses during prolonged sensory stimulation. Astrocytes release D-serine, which supports neuronal activity and contributes to dilation of brain blood vessels.
A nationwide survey in Japan found that most people with ALS and their families have never heard of patient and public involvement, but over 70% want to take part once explained. A patient advocacy training program was also successful, with 500 people registering and high comprehension scores.
Researchers hope to enroll over 2,000 stroke patients to test cilostazol's effectiveness in reducing stroke recurrence. The study aims to cut stroke recurrence by 50% and follows Japan's success with similar results.
Research found a significant association between living near industrial facilities emitting water pollutants and developing progressive supranuclear palsy (PSP), a rare movement disorder. People living within three miles of such facilities were 66% more likely to develop PSP than those who did not live nearby.
A Chinese Neurosurgical Journal study found that linear accelerator-based radiosurgery reduced seizure frequency by 75.6% in patients with drug-resistant mesial temporal lobe epilepsy. However, the approach was associated with several adverse events, including visual field deficits and recent memory impairment.
A study by National Institutes for Quantum Science and Technology researchers found that faster buildup of abnormal tau protein in the brain is linked to faster symptom worsening in progressive supranuclear palsy, a rare neurodegenerative disease. The discovery could help researchers objectively measure disease progression and accelera...
A new study reveals concerns about misdiagnosis and stigma in autoimmune diseases with functional neurological disorder (FND), highlighting the need for better communication and holistic care. Patients and clinicians often see things differently, and poor explanations can lead to feelings of guilt, shame, and suicidal thoughts.
Researchers found that hypomagnetic fields extend survival in a fly model of Parkinson's disease, but reduce mobility. The study suggests that magnetic field strength may be a potential therapeutic strategy, particularly in the context of ageing and neurodegenerative disease.
Researchers have developed a new therapeutic approach for SCA3, a rare neurodegenerative disease, by targeting the production of a harmful protein. The approach uses custom-designed drugs to reduce the levels of the disease-causing protein, preserving the normal protein's function.
The NFL has committed $500,000 to Champion Insights, a nationwide study investigating why elite athletes, military veterans, and first responders are at higher risk of developing ALS. The study aims to uncover genetic and biological factors that may lead to new treatments and strategies to prevent the disease.
Researchers discovered how HSV-1 changes the brain's immune cells response to infection, potentially triggering chronic inflammation and Alzheimer's disease. The virus activates powerful antiviral defenses in microglia, which may compromise their ability to maintain a healthy brain.
A new study from King's College London found that ethnic inequalities in stroke are primarily attributed to differences in traditional stroke risk factors, such as diabetes and high blood pressure. The study analyzed data from over 650,000 people in South London and found that Black and Asian patients were more likely to develop these ...
Upstate Medical University has been awarded $1.5 million to create an advanced research center for brain diseases, including Alzheimer's, Parkinson's, and stroke, as part of the SUNY Brain Institute. The center will integrate biospecimens, induced pluripotent stem cells, and organoid models to support human-centered neuroscience research.
Researchers have developed a new method to deliver disease-fighting antibodies directly to the brain, using extracellular vesicles to bypass the blood-brain barrier. This approach shows potential in treating neurodegenerative diseases such as Alzheimer's, Parkinson's, and ALS, by improving the elimination of pathological proteins.
A new study found significant disparities in access to anti-amyloid Alzheimer's treatments, with Black adults and Hispanic adults having lower odds of receiving the medication. However, once treatment began, patients were equally likely to take the medication as prescribed, regardless of their race or ethnicity.
Researchers developed an AI tool that analyzes genetic data to identify risk factors for stroke, which can lead to personalized risk assessments and targeted prevention strategies. The tool was more accurate than previous genetic risk tools in distinguishing people who had suffered a stroke from those who had not.
In a breakthrough, scientists discovered that Alzheimer's disease disrupts the brain's pacemaker cells, causing gamma oscillations to falter. By boosting levels of a specific protein, researchers were able to restore normal brain rhythms and improve cognitive function, offering a promising therapeutic target for the disease.
A new study from Toho University found that wearable robot training improved walking distance in patients with ALS by nearly 12 meters in a two-minute test, while quality of life remained stable. The study suggests that walking performance may improve without a measurable decline in quality of life, but larger controlled studies are ne...
The study, published in the journal Extracellular Vesicles, found that tiny vesicles produced by neural stem cells can carry medicines to the brain and spinal cord despite the blood-brain barrier. In mice, nasal delivery delayed disease onset, improved movement, and protected motor neurons.
Researchers at the University of Cincinnati have developed a proof-of-concept gene therapy that targets and reduces the production of cerebrospinal fluid, potentially providing a minimally invasive treatment for hydrocephalus. The therapy uses an adeno-associated virus to deliver therapeutic genetic material into a patient's cells, wit...
Oregon Health & Science University researchers are investigating the connection between gut damage and neuroinflammation in people with HIV. The $5.8 million study aims to develop new treatments to preserve brain function in people with HIV and older adults.
Researchers at Children's Hospital of Philadelphia identified a genetic variant in the MAP2K4 gene associated with neurodevelopmental disorder symptoms such as developmental delay and epilepsy. The study revealed impaired JNK signaling in induced pluripotent stem cell-derived neurons, providing a potential therapeutic target for furthe...
Juvmo, a Parkinson's disease drug, has been approved by the FDA and offers a new treatment option for patients, potentially reducing side effects. The drug's unique mechanism of action provides relief from motor symptoms, and its approval marks a significant milestone in the research of UVA Health scientists.
A large study led by Oregon State University found that brain cancer risk increases with exposure to elevated concentrations of radon, a known lung carcinogen. The research, published in Neuroepidemiology, suggests that residential radon exposure may contribute to the overall burden of central nervous system cancers.
Researchers found that people with a higher genetic risk for Alzheimer’s who volunteered or helped others showed slower cognitive decline. The study, which analyzed 22 years of data, found that even modest amounts of helping others provided significant cognitive benefits.
A new study from CU Anschutz finds horseback riding improves hyperactivity, irritability, and emotional regulation in children with autism and psychiatric diagnoses. Horse-related activities also provide benefits for those unable to ride, enhancing communication and emotional regulation skills.
A new research effort will use AI, large-scale experiments, and human-cell studies to predict harmful protein changes before neurodegenerative disease takes hold. The project, led by Stowers Institute scientist Randal Halfmann, will generate data on protein aggregation and train AI to identify proteins likely to go wrong.
A major clinical trial found that nicotinamide riboside (NR) provided no clinical benefit in early Parkinson’s disease, with participants experiencing worsening symptoms. The treatment did not slow or accelerate changes in the brain’s dopamine system, and the overall occurrence of adverse events was similar in both groups.
A new study from the Bogalusa Heart Study has found a significant association between cumulative clinical obesity and white matter changes in the brain by midlife. Researchers analyzed data from 190 participants and found that those with greater exposure to clinical obesity had worse brain health in midlife.
A study published in Neurology found that nearly one-third of people with epilepsy who took certain medications and hormonal contraceptives experienced reduced contraceptive effectiveness. The study highlights the need for greater awareness of interactions between enzyme-inducing antiseizure medications and hormonal contraceptives.
Nuclear medicine is experiencing rapid growth with over 50 million procedures performed worldwide each year. EANM'26 will present the latest advances in nuclear medicine, molecular imaging, and radiopharmaceuticals, including theranostics and next-generation imaging technology.
A new study found that the timing of Deep Brain Stimulation (DBS) surgery is critical for preserving cognitive function in Parkinson’s disease patients with a specific genetic mutation. Performing DBS within the first seven to eight years of diagnosis delays significant cognitive decline, while early intervention optimizes physical mob...
Scientists at FAU will investigate the molecular mechanisms underlying motor exit point glia function to understand how myelin-producing cells interact at the CNS-PNS boundary. The study aims to uncover whether healthy myelin-producing cells can repair damaged myelin and inform future strategies for nerve repair.
A new review published in Science highlights the critical role of X and Y chromosomes in shaping human health and disease, influencing immunity, metabolism, brain aging, and disease progression. Understanding these mechanisms could lead to sex-aware medicine and tailored treatment strategies.
A new wearable device can track changes in arm movement impairment caused by strokes, enabling clinicians to make real-time adjustments to therapy programs. The device uses a machine-learning algorithm to interpret movement data, providing a more accurate reflection of a patient's true condition.
Adults in their 60s with lower cognitive test scores were more likely to experience a future stroke, according to a new study in Sweden. The study, which examined nearly 5,000 older adults, found that those with lower cognitive function scores were at increased risk of stroke.
Researchers at Upstate Medical University identified a crucial mechanism for determining myelin length, which varies throughout the nervous system and influences nerve signal speed. The findings, published in PLOS Biology, provide new insight into how the brain and spinal cord organize nervous system wiring.
Common viral infections like influenza and COVID-19 may accelerate the onset and progression of ALS by triggering an inflammatory response in the nervous system. Researchers at McMaster University found that even non-infectious respiratory viruses can leave lasting changes to the nervous system, leading to accelerated disease progression.
Mount Sinai researchers identified how APOE4 damages brain blood vessels, promoting abnormal protein buildup and neurodegeneration. They found that blocking TGF-β signaling restored pericyte coverage, reducing fibrosis and vascular amyloid accumulation.
Mizzou researchers have developed an AI tool called MeLSI that can identify specific microbes driving key biological changes in the gut microbiome, which may indicate early warning signs of disease. The tool has shown promising results in detecting meaningful patterns in microbiome data that conventional methods miss.
The Michigan ADRC will support studies on basic science, clinical trials, caregiver interventions, and longitudinal research to advance Alzheimer's disease prevention, treatment, and care. The center aims to fast-track clinical trials and improve the health and well-being of caregivers.
Researchers at the University of Helsinki identified five brain profiles for depression, revealing distinct patterns of brain activity and connectivity. The study suggests that depression is not a biologically similar disease for everyone, and individualized treatment may be key to more effective care.
A new drug, Kamuvudine K-9, has been shown to preserve nerve fibers and halt neurological damage in a mouse model of multiple sclerosis. The drug, derived from HIV drugs, has been found to be more effective than existing treatments in restoring function and reducing inflammation.
A comprehensive review of the evidence links ultraprocessed foods to poorer cognitive outcomes and increased risk of dementia. The study highlights the need for further research to determine the causal relationship between these foods and brain health.
A novel software and hardware solution analyzes synaptic dysfunctions related to Autism Spectrum Disorders and similar complex neurological conditions. The technology, comprising a neural network model and hardware architecture, provides real-time, biologically relevant synaptic analysis.
Researchers identify elevated levels of meprin-β in brain and cerebrospinal fluid of people with Alzheimer's disease, particularly in advanced stages. This finding suggests a possible relationship between meprin-β and beta-amyloid accumulation, a hallmark of the disease.
Researchers identified two opposing patterns of brain gene activity in mice carrying autism-risk mutations, which vary by sex and respond differently to experimental drugs. The patterns, which are shared across multiple analyses, suggest that many different genetic mutations converge into a limited number of molecular brain states.
Researchers successfully transplanted human brain cells into mice, allowing for the study of brain disorders such as schizophrenia, epilepsy, and autism. The new model provides a unique opportunity to study the causes and mechanisms of these conditions, potentially leading to the development of new treatments.
JMIR Neurotechnology invites submissions on digital health technologies in Parkinson disease, focusing on measurement and intervention. The call for papers aims to address challenges in validation, reproducibility, and clinical integration of these measurements.
A study published in Neurology found that military veterans exposed to high-level blasts were more likely to develop conditions such as seizures, neuropathy, and stroke years later. Researchers also found an association between low-level blast exposure and a reduced risk of certain conditions like diabetes and high cholesterol.
The Cleveland Alzheimer’s Disease Research Center will receive funding to accelerate research for Alzheimer’s disease and related dementias. The center aims to understand why dementia progresses at different rates among individuals and across its various forms.
SUNY Optometry has established the nation's first SUNY Eye Biobank, a shared research resource to advance the study of age-related neurological and visual disorders. The biobank will support research into the relationship between the eye, brain, and age-related disease.